Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities
Y Jeong, Y Cho*, YK Kim*
Journal of Biomedical Science, 2026; 33, 37 [12.1, 4.6%] [PDF]
KDM4A erases the H3R17me2a mark, facilitating chromosome condensation
Y Cho, JW Hwang, GH Hyun, S Lee, DG Song, SN Kim, YK Kim*
Advanced Science, 2026; e14281 [14.1, 7.9%] [PDF]
Reversible arginine methylation regulates mitochondrial IDH2 activity: coordinated control by CARM1 and KDM3A/4A
Y Cho, J Winarto, DG Song, DH Na, KB Kang, SN Kim, YK Kim*
Cell Death & Disease, 2026; 17, 195 [9.6, 14.2%] [PDF]
Multilayered regulation of cytoskeletal protein abundance: autoregulatory mechanisms of actin and tubulin
Y Cho, YK Kim*
Experimental & Molecular Medicine, 2026; 58, 59-72 [12.9, 4.2%] [PDF]
Context-specific applications of CARM1 inhibitors: functional profiles of EZM2302 and TP-064
Y Cho, YK Kim*
Molecular Medicine, 2025; 31 (1), 322 [6.4, 15.0%] [PDF]
Multifaceted roles of CARM1 beyond histone arginine methylation
Y Cho, YK Kim*
Experimental & Molecular Medicine, 2025; 57, 2251-2263 [12.9, 4.2%] [PDF]
Reversible arginine methylation of PI3KC2α controls mitotic spindle dynamics
Y Cho, JW Hwang, MT Bedford, DH Na, DG Song, SN Kim, YK Kim*
Cell Communication and Signaling, 2025; 23 (1), 409 [8.9, 15.2%] [PDF]
CARM1 S217 phosphorylation by CDK1 in late G2 phase facilitates mitotic entry
Y Cho, DG Song, SN Kim, YK Kim*
Cell Death & Disease, 2025; 16 (1), 202 [8.1, 15.9%] [PDF]
CARM1 regulates tubulin autoregulation through PI3KC2α R175 methylation
Y Cho, JW Hwang, MT Bedford, DG Song, SN Kim, YK Kim*
Cell Communication and Signaling, 2025; 23 (1), 120 [8.2, 15.4%] [PDF]
CARM1 phosphorylation at S595 by p38γ MAPK drives ROS-mediated cellular senescence
Y Cho, YK Kim*
Redox Biology, 2024; 76, 103344 [10.7, 5.3%]
ROS-mediated cytoplasmic localization of CARM1 induces mitochondrial fission through DRP1 methylation
Y Cho, YK Kim*
Redox Biology, 2024; 73, 103212 [10.7, 5.3%]
SPC-180002, a SIRT1/3 dual inhibitor, impairs mitochondrial function and redox homeostasis and represents an antitumor activity
Y Cho, JW Hwang, NJ Park, J Moon, KH Ali, YH Seo, IS Kim*, SN Kim*, YK Kim*
Free Radical Biology and Medicine, 2023; 208, 73-87 [7.4, 11.0%]
PRMT7 inhibitor SGC8158 enhances doxorubicin-induced DNA damage and its cytotoxicity
A Jeong, Y Cho, M Cho, GU Bae, DG Song, SN Kim*, YK Kim*
International Journal of Molecular Sciences, 2022; 23 (20), 12323 [5.6, 20.9%]
A novel synthetic microtubule inhibitor exerts antiproliferative effects in multidrug resistant cancer cells and cancer stem cells
M Park, JW Hwang, Y Cho, S Kim, SH Han, J Yu, S Ha, WY Kim, SN Kim, IS Kim*, YK Kim*
Scientific Reports, 2021; 11 (1), 10822 [4.997, 19.3%]
Protein arginine methyltransferases: promising targets for cancer therapy
JW Hwang, Y Cho, GU Bae, SN Kim, YK Kim*
Experimental & Molecular Medicine, 2021; 53 (5), 788-808 [8.718, 5.4%]
Cancer stem cells as a potential target to overcome multidrug resistance
Y Cho, YK Kim*
Frontiers in Oncology, 2020; 10, 764 [4.848, 33.1%]